MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression ...

Navamedic has two loans to Observe Medical ASA, Loan 1 from 27 September 2019, where the current balance, including principal and accrued interest, is NOK 47,775,182 (as of Oct 31st, 2024) and Loan 2 ...

Developed by NXP for use with the MathWorks MATLAB and Simulink platform, the toolbox simplifies the design, testing, and ...

The new series of automotive three- to six-cell battery monitoring protection ICs are products developed in ISO 26262 compliant processes and are equipped with functions for monitoring automotive ...

Infineon Technologies AG announces the new OptiMOS 5 Linear FET 2, a MOSFET designed to provide the ideal trade-off between ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Bristol-Myers Squibb (BMY) stock was upgraded by Leerink Partners based on a potential sales boost for its schizophrenia ...

NXP Announces Industry-First Ultra-Wideband Wireless Battery Management System Solution NXP has unveiled its new, ...

November 2024 at the St. Regis Saadiyat Island Resort, Abu Dhabi, SIBEC 2024 is set to draw hundreds of fire and life safety ...

Power Queen, the leader in lithium battery technology, introduces its latest innovation: the 12V 280Ah Low Temperature Deep ...